CRP Apheresis in STEMI
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 202 participants.
Also called NCT04939805
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 202 participants
- Sponsor
- Registry
-
NCT04939805
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Austria, Germany
- Registry status
- Recruiting
Technical summary
Registry record NCT04939805. Randomized; single masking; primary purpose treatment. Start 2021-04-01 (actual); primary completion 2026-01-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CRP Apheresis in STEMI
- Condition
- ST Elevation Myocardial Infarction
- Condition
- C-Reactive Protein
- Condition
- Apheresis
- Condition
- Myocardial Injury
- Intervention (Device)
- Selective CRP apheresis using the PentraSorb®-CRP system
- Lead sponsor
- Medical University Innsbruck
Record details
- Record id
cardio:ct-nct04939805- Content hash
d2687b031a0daa5e3fc4bc353f803903c0ce24566c2cb441bfaa84861d09902c